Serum resistin and insulin-like growth factor-1 levels in patients with hypothyroidism and hyperthyroidism

Journal of Thyroid Research

Volumn 2013, Issue , 2013, Pages

  Eke Koyuncu, Ceren ^a   Turkmen Yildirmak, Sembol ^a   Temizel, Mustafa ^a   Ozpacaci, Tevfik ^a   Gunel, Pinar ^b   Cakmak, Mustafa ^c   Ozbanazi, Yüksel Gülen ^a  

^a OKMEYDANI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

^c Gulkent State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; RESISTIN; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID FUNCTION;

EID: 84879194061     PISSN: 20908067     EISSN: 20420072     Source Type: Journal    
DOI: 10.1155/2013/306750     Document Type: Article

References (24)

1. Kumar V., Abbas A. K., Nelson, Robbins and Cotran. Pathologic Basis of Disease 2005 7th
2. Pucci E., Chiovato L., Pinchera A., Thyroid and lipid metabolism. International Journal of Obesity 2000 24 2 S109 S112 2-s2.0-0033913054 10.1038/sj/ijo/0801292 (Pubitemid 30461962)
3. Antuna-Puente B., Feve B., Fellahi S., Bastard J. P., Adipokines: the missing link between insulin resistance and obesity. Diabetes and Metabolism 2008 34 1 2 11 2-s2.0-39149143637 10.1016/j.diabet.2007.09.004
4. Pontikides N., Krassas G. E., Basic endocrine products of adipose tissue in states of thyroid dysfunction. Thyroid 2007 17 5 421 431 2-s2.0-34249949583 10.1089/thy.2007.0016 (Pubitemid 46878845)
5. Ganong W. F., Ganong Medical Physiology 2002 16th
6. Nogueiras R., Gualillo O., Caminos J. E., Casanueva F. F., Diéguez C., Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obesity Research 2003 11 3 408 414 2-s2.0-0037532394 (Pubitemid 41151629)
7. Iglesias P., Alvarez Fidalgo P., Codoceo R., Díez J. J., Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clinical Endocrinology 2003 59 5 621 629 2-s2.0-0242288543 10.1046/j.1365-2265.2003. 01897.x (Pubitemid 37357624)
8. Botella-Carretero J. I., Alvarez-Blasco F., Sancho J., Escobar-Morreale H. F., Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal. Thyroid 2006 16 4 397 402 2-s2.0-33646515095 10.1089/thy.2006.16.397
9. Krassas G. E., Pontikides N., Loustis K., Koliakos G., Constantinidis T., Kaltsas T., Resistin levels are normal in hypothyroidism and remain unchanged after attainment of euthyroidism: relationship with insulin levels and anthropometric parameters. Journal of Endocrinological Investigation 2006 29 7 606 612 2-s2.0-33749008228 (Pubitemid 44446270)
10. Yaturu S., Prado S., Grimes S. R., Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. Journal of Cellular Biochemistry 2004 93 3 491 496 2-s2.0-15044350554 10.1002/jcb.20188 (Pubitemid 44264184)
11. Syed M. A., Thompson M. P., Pachucki J., Burmeister L. A., The effect of thyroid hormone on size of fat depots accounts for most of the changes in leptin mRNA and serum levels in the rat. Thyroid 1999 9 5 503 512 2-s2.0-0033023412 (Pubitemid 29244929)
12. Krassas G. E., Pontikides N., Loustis K., Koliakos G., Constantinidis T., Panidis D., Resistin levels in hyperthyroid patients before and after restoration of thyroid function: relationship with body weight and body composition. European Journal of Endocrinology 2005 153 2 217 221 2-s2.0-23844495224 10.1530/eje.1.01963 (Pubitemid 41167479)
13. Silha J. V., Krsek M., Hana V., Marek J., Jezkova J., Weiss V., Murphy L. J., Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clinical Endocrinology 2003 58 6 736 742 2-s2.0-0038807882 10.1046/j.1365-2265.2003.01789.x (Pubitemid 36702734)
14. Melmed S., Acromegaly. The New England Journal of Medicine 1990 322 14 966 977 2-s2.0-0025700486
15. Sönksen P. H., Greenwood F. C., Ellis J. P., Lowy C., Rutherford A., Nabarro J. D. N., Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment. The Journal of Clinical Endocrinology and Metabolism 1967 27 10 1418 1430 2-s2.0-0014138282 10.1210/jcem-27-10-1418
16. Wasada T., Aoki K., Sato A., Katsumori K., Muto K., Tomonaga O., Yokoyama H., Iwasaki N., Babazono T., Takahashi C., Iwamoto Y., Omori Y., Hizuka N., Assessment of insulin resistance in acromegaly associated with diabetes mellitus before and after transsphenoidal adenomectomy. Endocrine Journal 1997 44 4 617 620 2-s2.0-9844261155 (Pubitemid 27406774)
17. Chiba T., Yamaza H., Komatsu T., Nakayama M., Fujita S., Hayashi H., Higami Y., Shimokawa I., Pituitary growth hormone suppression reduces resistin expression and enhances insulin effectiveness. Relationship with caloric restriction. Experimental Gerontology 2008 43 6 595 600 2-s2.0-43649098702 10.1016/j.exger.2008.03.003
18. Chen Y. H., Hung P. F., Kao Y. H., IGF-I downregulates resistin gene expression and protein secretion. American Journal of Physiology 2005 288 5 E1019 E1027 2-s2.0-17444421501 10.1152/ajpendo.00325.2004 (Pubitemid 40547897)
19. Willemsen R. H., Dijk M., Rijke Y. B., Toorenenbergen A. W., Mulder P. G., Hokken-Koelega A. C., Effect of growth hormone therapy on serum adiponectin and resistin levels in short, small-for-gestational-age children and associations with cardiovascular risk parameters. Journal of Clinical Endocrinology and Metabolism 2007 92 1 117 123 2-s2.0-33846039970 10.1210/jc.2006-0852 (Pubitemid 46067518)
20. Nozue H., Kamoda T., Matsui A., Serum resistin concentrations in growth hormone-deficient children during growth hormone replacement therapy. Metabolism 2007 56 11 1514 1517 2-s2.0-35248844576 10.1016/j.metabol.2007.06.018 (Pubitemid 47562502)
21. Schmid C., Zwimpfer C., Brändle M., Krayenbühl P. A., Zapf J., Wiesli P., Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism. Clinical Endocrinology 2006 65 6 706 711 2-s2.0-33751090323 10.1111/j.1365-2265. 2006.02652.x (Pubitemid 44772348)
22. Völzke H., Friedrich N., Schipf S., Haring R., Lüdemann J., Nauck M., Dörr M., Brabant G., Wallaschofski H., Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study. Journal of Clinical Endocrinology and Metabolism 2007 92 10 4039 4045 2-s2.0-35348933211 10.1210/jc.2007-0816 (Pubitemid 47607658)
23. Kursunluoglu R., Turgut S., Akin F., Bastemir M., Kaptanoglu B., Genc O., Turgut G., Insulin-like growth factor-I gene and insulin-like growth factor binding protein-3 polymorphism in patients with thyroid dysfunction. Archives of Medical Research 2009 40 1 42 47 2-s2.0-57049130487 10.1016/j.arcmed.2008.10. 009
24. Akin F., Yaylali G. F., Turgut S., Kaptanoglu B., Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction. Growth Hormone and IGF Research 2009 19 3 252 255 2-s2.0-67349225403 10.1016/j.ghir.2008.11.003